运动心电图异常而负荷超声心动图正常的意义
该观察性队列研究纳入杜克大学医学中心2000年1月1日至2014年2月28日连续47944例无已知冠心病行运动负荷超声心动图患者,排除次极量运动及无法诊断的心电图或负荷影像结果后,15077例(平均年龄52岁,41.3%男性)分为双阴性(12893例,85.5%)、心电图阳性/超声正常(1286例,8.5%)和超声阳性(898例,6.0%)三组。中位随访7.3年,复合终点(死亡、心肌梗死、不稳定型心绞痛住院和血运重建)发生率分别为8.5%、14.6%和37.4%。心电图阳性/超声正常组复合终点和心肌梗死发生率高于双阴性组,但死亡发生率相近。作者认为该不一致结果可能识别出既往未认识到的风险略增人群,需进一步研究确定强化药物治疗是否获益。
要点
- 运动心电图阳性而负荷超声心动图正常的患者(1286例,8.5%)复合终点发生率14.6%,高于双阴性患者的8.5%。
- 该组心肌梗死发生率3.6%,高于双阴性组的2.2%;死亡发生率5.9%,与双阴性组的4.8%相近。
- 超声阳性组(898例,6.0%)复合终点发生率37.4%,死亡11.2%,心肌梗死8.7%,风险最高。
- 心电图阳性/超声正常组下游检查率12.8%,高于双阴性组的2.3%,低于超声阳性组的33.6%(P < .001)。
- 将运动心电图结果加入临床和运动数据可提供增量预后价值。
适用人群与场景
- 2000年1月1日至2014年2月28日在杜克大学医学中心行运动负荷超声心动图的连续患者,无已知冠心病,共47944例接受评估。
- 排除次极量运动试验及无法诊断的心电图或负荷影像结果后,最终分析15077例(平均年龄52岁,41.3%男性)。
研究设计与关键结果
- 观察性队列研究,最终纳入15077例无已知冠心病行运动负荷超声心动图患者,分为双阴性(12893例,85.5%)、心电图阳性/超声正常(1286例,8.5%)和超声阳性(898例,6.0%)三组。
- 中位随访7.3年(四分位距4.4-10.0年),复合终点(死亡、心肌梗死、不稳定型心绞痛住院和血运重建)发生率:双阴性组8.5%(794例),心电图阳性/超声正常组14.6%(142例),超声阳性组37.4%(297例)。
- 死亡发生率:双阴性组4.8%(425例),心电图阳性/超声正常组5.9%(50例),超声阳性组11.2%(70例)。
- 心肌梗死发生率:双阴性组2.2%(195例),心电图阳性/超声正常组3.6%(31例),超声阳性组8.7%(59例)。
- 将运动心电图结果加入临床和运动数据可提供增量预后价值。
- 下游检查率:双阴性组2.3%,心电图阳性/超声正常组12.8%,超声阳性组33.6%(P < .001)。
证据类型、等级与局限
- 证据类型:观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,运动心电图阳性而负荷超声心动图正常可能识别出既往未认识到的风险略增人群。
- 作者指出,需进一步研究确定这些患者是否会从强化药物治疗中获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Patients with abnormal (positive) exercise electrocardiography, but normal stress echocardiography (+ECG/-Echo) are commonly encountered in clinical practice; however, the prognostic significance of this discordant result is unclear.
OBJECTIVE: To determine whether patients with +ECG/-Echo have a higher rate of adverse clinical events and a poorer prognosis than patients with negative exercise ECG and normal stress Echo imaging (-ECG/-Echo).
DESIGN, SETTING, AND PARTICIPANTS: Between January 1, 2000, and February 28, 2014, a total of 47 944 consecutive patients without known coronary artery disease who underwent exercise stress Echo at Duke University Medical Center were evaluated for inclusion in this observational cohort study. Data analysis was conducted from January 1, 2000, to December 31, 2016.
INTERVENTIONS/EXPOSURES: Patients were categorized as having -ECG/-Echo, +ECG/-Echo, or +Echo (-ECG/+Echo and +ECG/+Echo).
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite end point of death, myocardial infarction, hospitalization for unstable angina, and coronary revascularization. Secondary outcomes included individual adverse events and downstream testing.
RESULTS: After excluding submaximal tests and nondiagnostic ECG or stress imaging results, 15 077 patients (mean [SD] age, 52 [13] years; 6228 [41.3%] men) were classified by stress test results. Of these, 12 893 patients (85.5%) had -ECG/-Echo, 1286 patients (8.5%) had +ECG/-Echo, and 898 patients (6.0%) had +Echo. Through a median follow-up of 7.3 (interquartile range, 4.4-10.0) years, the composite end point occurred in 794 patients with -ECG/-Echo (8.5%), 142 patients with +ECG/-Echo (14.6%), and 297 patients with +Echo (37.4%). Death occurred in 425 patients with -ECG/-Echo (4.8%), 50 patients with +ECG/-Echo (5.9%), and 70 patients with +Echo (11.2%). Myocardial infarction occurred in 195 patients with -ECG/-Echo (2.2%), 31 patients with +ECG/-Echo (3.6%), and 59 patients with +Echo (8.7%). The addition of stress ECG findings to clinical and exercise data yielded incremental prognostic value. Patients with -ECG/-Echo imaging results had the least downstream testing (2.3%), followed by +ECG/-Echo (12.8%), and +Echo (33.6%) (P < .001).
CONCLUSIONS AND RELEVANCE: The presence of +ECG results with normal stress Echo imaging may identify a population of patients who are at slightly increased risk for adverse cardiac events, which was not previously recognized. Further study is needed to determine whether these patients will benefit from intensification of medical management.
参考来源
- Daubert MA, Sivak J, Dunning A, et al. Implications of Abnormal Exercise Electrocardiography With Normal Stress Echocardiography. JAMA Intern Med. 2020. PMID: 31985749. doi:10.1001/jamainternmed.2019.6958
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。